Wearable Health Monitors: What Your Smartwatch Can and Ca...

Innovation & Technology · 5 · December 14, 2025

The Apple Watch's ECG function has detected atrial fibrillation in over 500,000 users since its 2018 launch — with a positive predictive value of 84% confirmed by a Stanford study published in the New England Journal of Medicine. Wearables are no longer toys. They're screening tools.

ECG and Heart Rhythm Monitoring

Apple Watch (Series 4+), Samsung Galaxy Watch (4+), and Withings ScanWatch offer single-lead ECG recording with FDA-cleared afib detection algorithms. Accuracy: 98.3% specificity and 84% sensitivity for atrial fibrillation (Stanford Apple Heart Study). Limitations: single-lead ECG can't diagnose heart attacks, detect all arrhythmias, or replace a 12-lead clinical ECG. Best use: screening for intermittent atrial fibrillation in at-risk populations — a condition that affects 33 million people globally and increases stroke risk 5x.

Continuous Glucose Monitoring Goes Mainstream

Abbott's FreeStyle Libre 3 and Dexcom G7 are prescription CGMs that provide real-time glucose readings every 1-5 minutes via a small sensor worn on the arm. Originally for diabetics, CGMs are now used by biohackers, athletes, and pre-diabetics for metabolic optimization. Non-prescription CGM (Lingo by Abbott, Stelo by Dexcom) launched in 2024 for general wellness — $89-$99/month without a prescription.

For medical tourists with diabetes: wearing a CGM during travel provides continuous glucose data that helps manage the stress, diet changes, and medication adjustments that come with being in a foreign country during recovery. Several international hospitals now request CGM data as part of pre-operative diabetic optimization.

Post-Surgical Remote Monitoring

The most promising clinical application of wearables: post-discharge monitoring for surgical patients. Companies like BioIntelliSense (BioButton) and Current Health offer medical-grade wearable patches that continuously monitor heart rate, respiratory rate, temperature, and SpO2 — transmitting data to the treating hospital. For medical tourism patients who fly home 5-7 days after surgery, wearable monitoring provides a safety net during the vulnerable early recovery period.

Key Takeaways

- Apple Watch ECG has detected afib in 500,000+ users with 84% sensitivity

- Non-prescription CGMs are now available for $89-$99/month for general wellness monitoring

- Post-surgical wearable patches can monitor heart rate, respiratory rate, and SpO2 remotely

- Wearable monitoring during medical tourism recovery provides a safety net after early discharge

Compare real-time pricing using our global cost calculator.